Last updated: 20 May 2024 at 8:15pm EST

Natasha Hernday Net Worth



Natasha Hernday biography

Natasha A. Hernday serves as Independent Director of the Company. Ms. Hernday has served as a member of the leadership team of Seattle Genetics, Inc., a publicly-traded biotechnology company, since January 2011. She is currently its Senior Vice President, Corporate Development. At Seattle Genetics, Ms. Hernday built and led the business development team responsible for sourcing, evaluating and negotiating licensing deals, acquisitions and partnerships. From July 1994 until January 2011, Ms. Hernday served in various roles of increasing responsibility at Amgen, including Director, Mergers & Acquisitions and Director, Out-Partnering. Ms. Hernday received her B.A. in microbiology from the University of California at Santa Barbara and her M.B.A. from Pepperdine University.

What is the salary of Natasha Hernday?

As the Independent Director of PDL Biopharma Inc, the total compensation of Natasha Hernday at PDL Biopharma Inc is 202,778$. There are 6 executives at PDL Biopharma Inc getting paid more, with Dominique Monnet having the highest compensation of 6,701,000$.



How old is Natasha Hernday?

Natasha Hernday is 48, she's been the Independent Director of PDL Biopharma Inc since 2019. There are 7 older and no younger executives at PDL Biopharma Inc. The oldest executive at PDL Biopharma Inc is John McLaughlin, 68, who is the Director.

What's Natasha Hernday's mailing address?

Natasha's mailing address filed with the SEC is C/O ALPINE IMMUNE SCIENCES, INC., 188 EAST BLAINE STREET, SUITE 200, SEATTLE, WA, 98102.

Insiders trading at PDL Biopharma Inc

Over the last 22 years, insiders at PDL Biopharma Inc have traded over 45,966,964$ worth of PDL Biopharma Inc stock and bought 12,693,393 units worth 32,804,545$ . The most active insiders traders include Point Capital L.P.O'shea Ro...Faheem HasnainLaurence Jay Korn. On average, PDL Biopharma Inc executives and independent directors trade stock every 24 days with the average trade being worth of 245,074,578$. The most recent stock trade was executed by Point Capital L.P.O'shea Ro... on 1 February 2021, trading 187,061 units of PDLI stock currently worth 383,475$.



What does PDL Biopharma Inc do?



PDL Biopharma Inc executives and stock owners

PDL Biopharma Inc executives and other stock owners filed with the SEC include: